Delaying Medicare’s ability to negotiate prices on small-molecule drugs until 13 years after FDA approval will decrease the ...

President Trump will introduce a "most favored nation" plan aimed at cutting Medicare drug prices by linking them to the ...

The Food and Drug Administration on Thursday announced an aggressive agency-wide Artificial intelligence adoption timeline ...

The U.S. Food and Drug Administration said Tuesday it will expand its use of unannounced inspections at foreign manufacturing ...

Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.

Federal health agencies will create a database of autism patients enrolled in Medicare and Medicaid that researchers will use ...

Federal health officials didn’t provide information about how people’s private medical data will be collected and managed.

The Food and Drug Administration (FDA ... loss and weight management medication for certain people with obesity. Medicare Part D prescription drug plans may cover Zepbound when a doctor prescribes ...

Learn about the benefits that become permanent features of Medicare in 2026 and how they have been changed or updated since ...

Federal health officials want to collect individuals' health data so they can answer questions about autism and chronic ...

Policies and actions reshaping the healthcare industry began pouring out of President Donald Trump’s White House nearly from ...

The National Institutes of Health (NIH) and the Centers for Medicare & Medicaid Services (CMS) are partnering to develop a ...